Literature DB >> 12145320

Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics.

Paraskevi Giannakakou1, Michel Nakano, Kyriacos C Nicolaou, Aurora O'Brate, Jian Yu, Mikhail V Blagosklonny, Urs F Greber, Tito Fojo.   

Abstract

The tumor suppressor protein p53 localizes to microtubules (MT) and, in response to DNA damage, is transported to the nucleus via the MT minus-end-directed motor protein dynein. Dynein is also responsible for MT-mediated nuclear targeting of adenovirus type 2 (Ad2). Here we show that treatment with low concentrations of MT-targeting compounds (MTCs) that do not disrupt the MT network but are known to suppress MT dynamics enhanced p53 nuclear accumulation, and the activation of the p53-downstream target genes. p53 nuclear accumulation required binding of MTCs to MTs and enhanced the induction of p53-up-regulated modulator of apoptosis (PUMA) mRNA and apoptosis on challenging cells with the DNA-damaging drug adriamycin. Low concentrations of MTCs enhanced the rate of movement of fluorescent Ad2 to the nucleus and increased the nuclear targeting efficiency of Ad2. We propose that suppression of MT dynamics by low concentrations of MTCs enhances MT-dependent trafficking toward the minus ends of MTs and facilitates nuclear targeting.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145320      PMCID: PMC125062          DOI: 10.1073/pnas.132275599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.

Authors:  G S Jimenez; S H Khan; J M Stommel; G M Wahl
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

2.  Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.

Authors:  Z A Stewart; L J Tang; J A Pietenpol
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

Review 3.  Regulation of p53 function.

Authors:  D B Woods; K H Vousden
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

Review 4.  p53: death star.

Authors:  K H Vousden
Journal:  Cell       Date:  2000-11-22       Impact factor: 41.582

5.  p53 is associated with cellular microtubules and is transported to the nucleus by dynein.

Authors:  P Giannakakou; D L Sackett; Y Ward; K R Webster; M V Blagosklonny; T Fojo
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

Review 6.  Structural insights into microtubule function.

Authors:  E Nogales
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

7.  Adenovirus-activated PKA and p38/MAPK pathways boost microtubule-mediated nuclear targeting of virus.

Authors:  M Suomalainen; M Y Nakano; K Boucke; S Keller; U F Greber
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 8.  The taxanes: an update.

Authors:  J Crown; M O'Leary
Journal:  Lancet       Date:  2000-04-01       Impact factor: 79.321

9.  Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.

Authors:  V K Ngan; K Bellman; D Panda; B T Hill; M A Jordan; L Wilson
Journal:  Cancer Res       Date:  2000-09-15       Impact factor: 12.701

Review 10.  Viral transport and the cytoskeleton.

Authors:  A Ploubidou; M Way
Journal:  Curr Opin Cell Biol       Date:  2001-02       Impact factor: 8.382

View more
  68 in total

Review 1.  Molecular pharmacodynamics in childhood leukemia.

Authors:  R Pieters; M L den Boer
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

2.  Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Authors:  Donna M Barten; Patrizia Fanara; Cathy Andorfer; Nina Hoque; P Y Anne Wong; Kristofor H Husted; Gregory W Cadelina; Lynn B Decarr; Ling Yang; Victoria Liu; Chancy Fessler; Joan Protassio; Timothy Riff; Holly Turner; Christopher G Janus; Sethu Sankaranarayanan; Craig Polson; Jere E Meredith; Gemma Gray; Amanda Hanna; Richard E Olson; Soong-Hoon Kim; Gregory D Vite; Francis Y Lee; Charles F Albright
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

3.  Intracellular trafficking of plasmids during transfection is mediated by microtubules.

Authors:  Erin E Vaughan; David A Dean
Journal:  Mol Ther       Date:  2005-11-21       Impact factor: 11.454

4.  FRAP analysis of nucleocytoplasmic dynamics of the vitamin D receptor splice variant VDRB1: preferential targeting to nuclear speckles.

Authors:  Kathryn L Sunn; John A Eisman; Edith M Gardiner; David A Jans
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

5.  A model for intracellular trafficking of adenoviral vectors.

Authors:  Anh-Tuan Dinh; Theo Theofanous; Samir Mitragotri
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

Review 6.  Interphase microtubules: chief casualties in the war on cancer?

Authors:  Angela Ogden; Padmashree C G Rida; Michelle D Reid; Ritu Aneja
Journal:  Drug Discov Today       Date:  2013-11-04       Impact factor: 7.851

7.  Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.

Authors:  Sten Strunze; Lloyd C Trotman; Karin Boucke; Urs F Greber
Journal:  Mol Biol Cell       Date:  2005-04-06       Impact factor: 4.138

8.  Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model.

Authors:  Charles Walker; Stefanie Böttger; Ben Low
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

9.  Intact microtubules support adenovirus and herpes simplex virus infections.

Authors:  Hélène Mabit; Michel Y Nakano; Ute Prank; Bianca Saam; Katinka Döhner; Beate Sodeik; Urs F Greber
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling.

Authors:  M Sung; P Giannakakou
Journal:  Oncogene       Date:  2013-03-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.